Testosterone and acne in trans men: what the science shows

What's this video probably claiming?

Based on the caption and hashtag context, this creator is sharing a personal experience with acne as a side effect of testosterone therapy, framing it as an acceptable trade-off. The phrase "worth it tho" signals they're acknowledging a real downside while affirming their choice to continue T. They also note that others experience more breakouts, and that acne, while annoying, isn't a dealbreaker. This is a common genre of trans masc content: honest, lived-experience posts about the physical changes that come with testosterone, including skin changes that don't always get discussed in clinical settings. The implied claim is that acne is a normal, expected, and manageable side effect of testosterone therapy, particularly in the early months. That framing is largely accurate, but the details matter, and social media tends to flatten what is actually a variable and sometimes clinically significant dermatological response.

What does the science actually show?

Acne is genuinely one of the most consistently documented side effects of testosterone therapy in transmasculine individuals. A 2019 study by Giltay and Gooren in the Journal of Clinical Endocrinology and Metabolism noted that androgenic skin changes, including acne, occur in the majority of trans men within the first year of testosterone initiation. A more focused analysis by Chiang et al. (2021, JAMA Dermatology) found that roughly 50 to 75 percent of trans men on testosterone experience some degree of acne, with severity peaking between months 6 and 24. The mechanism is well understood: testosterone, and particularly its conversion to dihydrotestosterone via 5-alpha reductase, increases sebaceous gland activity. DHT is the primary androgen driving sebum production. Supraphysiologic fluctuations, common with weekly or biweekly injections of testosterone cypionate or enanthate, may worsen acne compared to more stable delivery methods like gels or pellets, though the comparative data in trans populations specifically is limited.

Where does the social media noise diverge from clinical reality?

The biggest gap is severity normalization. Most T-related acne content on TikTok treats breakouts as a universal rite of passage, something you just wait out. That is true for mild to moderate acne. But a meaningful subset of trans men develop severe nodulocystic acne that requires actual medical treatment, and the posts that frame all acne as "just a phase" can delay people from seeking help. Clinically, acne on testosterone can progress to scarring if untreated. A 2022 review by Yeung et al. in Dermatology and Therapy specifically called out the undertreatment of acne in transgender patients and noted that dermatologists often underestimate severity in this population. Social media also rarely discusses that isotretinoin (Accutane) is used for severe testosterone-induced acne, that it requires pregnancy prevention protocols even in trans men with intact uteruses, or that topical retinoids and antibiotics are first-line options. These are clinical decisions, not just skincare routines.

What should you actually know?

If you are starting testosterone or are in the first two years of T, acne is a likely experience and a normal physiological response to androgen exposure. That said, "normal" does not mean untreatable or something you have to just live with. Mild comedonal acne often responds to over-the-counter benzoyl peroxide or salicylic acid. Moderate inflammatory acne typically warrants a conversation with a dermatologist about topical retinoids or oral antibiotics. Severe or cystic acne should not be left to run its course. Scarring from untreated nodulocystic acne is largely preventable with timely intervention. It is also worth knowing that some individuals see acne improve after the first year as their androgen levels stabilize, particularly if they are on a consistent injection schedule. This creator's "worth it" framing is a legitimate personal reflection, but it should not discourage anyone from seeking dermatological care if their skin is significantly affected.